Omega Healthcare Investors, Inc. announced its Q4 2023 results, featuring a net income of $57 million, or $0.22 per common share, and adjusted funds from operations (AFFO) of $173 million, or $0.68 per common share. The company completed $249 million in new investments and sold 32 facilities for $324 million, with improving portfolio operating performance.
Net income for the quarter was $57 million, or $0.22 per common share.
Adjusted Funds From Operations (AFFO) reached $173 million, or $0.68 per common share.
New investments totaled $249 million, including real estate loans and acquisitions.
32 facilities were sold for $324 million, generating a $10 million gain.
Omega Healthcare anticipates its 2024 first and second quarter earnings to continue to be impacted by restructuring efforts. The company expects its 2024 Adjusted FFO to be between $2.70 and $2.80 per diluted share.
Visualization of income flow from segment revenue to net income